These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 28820684)

  • 1. Lack of Efficacy of Liposomal Amphotericin B Against Acute and Chronic
    Clemons KV; Sobel RA; Martinez M; Correa-Oliveira R; Stevens DA
    Am J Trop Med Hyg; 2017 Oct; 97(4):1141-1146. PubMed ID: 28820684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo activity of amphotericin B-lipid formulations against experimental Trypanosoma cruzi infections.
    Yardley V; Croft SL
    Am J Trop Med Hyg; 1999 Aug; 61(2):193-7. PubMed ID: 10463666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parasitic loads in tissues of mice infected with Trypanosoma cruzi and treated with AmBisome.
    Cencig S; Coltel N; Truyens C; Carlier Y
    PLoS Negl Trop Dis; 2011 Jun; 5(6):e1216. PubMed ID: 21738811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of voriconazole in a murine model of acute Trypanosoma cruzi infection.
    Gulin JE; Eagleson MA; Postan M; Cutrullis RA; Freilij H; Bournissen FG; Petray PB; Altcheh J
    J Antimicrob Chemother; 2013 Apr; 68(4):888-94. PubMed ID: 23212113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited Ability of Posaconazole To Cure both Acute and Chronic Trypanosoma cruzi Infections Revealed by Highly Sensitive In Vivo Imaging.
    Francisco AF; Lewis MD; Jayawardhana S; Taylor MC; Chatelain E; Kelly JM
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4653-61. PubMed ID: 26014936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiprotozoal drug nitazoxanide enhances parasitemia, tissue lesions and mortality caused by Trypanosoma cruzi in murine model.
    Valle-Reyes JS; Melnikov V; Dobrovinskaya O; Rodriguez-Hernández A; Wookee-Zea C; Pimientel-Rodrigez V; Rueda-Valdovinos G; Delgado-Enciso I; López-Lemus UA; Espinoza-Gómez F
    Exp Parasitol; 2017 Jan; 172():44-50. PubMed ID: 28011170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D overload and experimental Trypanosoma cruzi infection: parasitological and histopathological aspects.
    Silva ME; Silva ME; Silva ME; Nicoli JR; Bambirra EA; Vieira EC
    Comp Biochem Physiol Comp Physiol; 1993 Jan; 104(1):175-81. PubMed ID: 8094657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug repurposing strategy against Trypanosoma cruzi infection: In vitro and in vivo assessment of the activity of metronidazole in mono- and combined therapy.
    Simões-Silva MR; De Araújo JS; Oliveira GM; Demarque KC; Peres RB; D'Almeida-Melo I; Batista DGJ; Da Silva CF; Cardoso-Santos C; Da Silva PB; Batista MM; Bahia MT; Soeiro MNC
    Biochem Pharmacol; 2017 Dec; 145():46-53. PubMed ID: 28870526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease.
    Rial MS; Scalise ML; Arrúa EC; Esteva MI; Salomon CJ; Fichera LE
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006119. PubMed ID: 29267280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of benznidazole treatment combined with nifurtimox, posaconazole or AmBisome® in mice infected with Trypanosoma cruzi strains.
    Cencig S; Coltel N; Truyens C; Carlier Y
    Int J Antimicrob Agents; 2012 Dec; 40(6):527-32. PubMed ID: 23063742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly diluted medication reduces tissue parasitism and inflammation in mice infected by Trypanosoma cruzi.
    Lopes CR; Falkowski GJ; Brustolin CF; Massini PF; Ferreira ÉC; Moreira NM; Aleixo DL; Kaneshima EN; de Araújo SM
    Homeopathy; 2016 May; 105(2):186-93. PubMed ID: 27211326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain.
    Cevey ÁC; Mirkin GA; Penas FN; Goren NB
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):12-22. PubMed ID: 26862474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects of an alternative treatment against Trypanosoma cruzi based on abietic acid derivatives show promising results in Balb/c mouse model.
    Olmo F; Guardia JJ; Marin C; Messouri I; Rosales MJ; Urbanová K; Chayboun I; Chahboun R; Alvarez-Manzaneda EJ; Sánchez-Moreno M
    Eur J Med Chem; 2015 Jan; 89():683-90. PubMed ID: 25462275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing and exploring active N'-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against three Trypanosoma cruzi strains more prevalent in Chagas disease patients.
    Palace-Berl F; Pasqualoto KF; Jorge SD; Zingales B; Zorzi RR; Silva MN; Ferreira AK; de Azevedo RA; Teixeira SF; Tavares LC
    Eur J Med Chem; 2015; 96():330-9. PubMed ID: 25899337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentamidine exerts in vitro and in vivo anti Trypanosoma cruzi activity and inhibits the polyamine transport in Trypanosoma cruzi.
    Díaz MV; Miranda MR; Campos-Estrada C; Reigada C; Maya JD; Pereira CA; López-Muñoz R
    Acta Trop; 2014 Jun; 134():1-9. PubMed ID: 24560964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic action of MK-436 (2,5-nitroimidazole) on Trypanosoma cruzi infections in mice: a parasitological, serological, histopathological, and ultrastructural study.
    Andrade SG; Silva RC; Santiago CM; Freitas LA
    Bull World Health Organ; 1987; 65(5):625-33. PubMed ID: 3123082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of PCR-positive tissue in benznidazole-treated mice with negative blood parasitological and serological tests in dual infections with Trypanosoma cruzi stocks from different genotypes.
    Martins HR; Figueiredo LM; Valamiel-Silva JC; Carneiro CM; Machado-Coelho GL; Vitelli-Avelar DM; Bahia MT; Martins-Filho OA; Macedo AM; Lana M
    J Antimicrob Chemother; 2008 Jun; 61(6):1319-27. PubMed ID: 18343804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of specific treatment on parasitological and histopathological parameters in mice infected with different Trypanosoma cruzi clonal genotypes.
    Toledo MJ; Bahia MT; Veloso VM; Carneiro CM; Machado-Coelho GL; Alves CF; Martins HR; Cruz RE; Tafuri WL; Lana M
    J Antimicrob Chemother; 2004 Jun; 53(6):1045-53. PubMed ID: 15102747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection.
    Gulin JEN; Bisio M; Rocco DM; Altcheh J; Solana ME; García-Bournissen F
    Exp Parasitol; 2018 Mar; 186():50-58. PubMed ID: 29448038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-time PCR strategy for parasite quantification in blood and tissue samples of experimental Trypanosoma cruzi infection.
    Caldas S; Caldas IS; Diniz Lde F; Lima WG; Oliveira Rde P; Cecílio AB; Ribeiro I; Talvani A; Bahia MT
    Acta Trop; 2012 Sep; 123(3):170-7. PubMed ID: 22609548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.